Jiang et al. discovered that by targeting MLKL in human HK2 cells, hsa-miR-500a-3P could attenuate toxic and ischemic insults caused by cell necroptosis and the inflammatory response in acute kidney injury (AKI) (50). Here, MLKL is linked to acute kidney injury.